Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹M.D. Asistant Professor, Necmettin Erbakan University Faculty of Medicine, Department of Ophthalmology, Konya/TURKEY
²M.D. Associate Professor, Necmettin Erbakan University Faculty of Medicine, Department of Ophthalmology, Konya/TURKEY Considered as one of the main reasons of visual loss of retinal origin, central serous chorioretinopathy (CSCR) is characterised neurosensorial reinal detachment caused by one or more focal leakage points on retinal pigment epithelium. It has been reported to be seen mostly in young male adults with an annual incidence rate of 10 per 10.000. Many risk factors have been identified including hypercortisolism, type-A personality and pregnancy. CSCR has been classified as acute, recurrent and chronic, in which acute form usually resolves in 2-3 months. Optical coherence tomography is valuable for both imaging subtle fundoscopic findings and monitoring disease progression. Fluorescein angiography aids identification of pigment epithelial leaks and guides argon laser treatment if outside the fovea. Where the diagnosis is uncertain, indocyanine green angiography can demonstrate classic midphase hyperpermeability. Treatment should be considered in chronic forms and acute forms lasting beyond 3 months. Long term results of therapy is not yet well established. Treatment options are argon laser photocoagulatin, half-fluence photodynamic therapy, micropulse diod laser, transpupillary thermotherapy, intravitreal anti-vascular endothelial growth factor injection and various pharmacologic ajents. Prognosis mostly depends on presenting visual acuity, and is usually good excluding chronic and bullous forms. This paper reviews epidemiology, risk factors, classification, diagnosis and treatment modalities of CSCR. Keywords : Maculopathy, central serous chorioretinopathy, central serous retinopathy, photodynamic therapy